Navigation Links
Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies

BLOOMFIELD, N.J., March 20, 2007 /PRNewswire-FirstCall/ -- Alfacell Corporation's ONCONASE (ranpirnase) has shown potential to act as a potent payload in antibody conjugates for cancer therapy, according to the latest edition of the Handbook of Therapeutic Antibodies.

In a chapter of the text that reviews immunotoxins, Susanna Rybak, Ph.D. summarizes preclinical research indicating that the specificity and potency of ONCONASE improves in a number of tumor models, including non-Hodgkin's lymphoma, when it is conjugated with various antibodies. Dr. Rybak also reviews evidence that implies that ONCONASE may also be effectively targeted to tumors as a conjugate with non-internalizing antibodies, as compared with the internalizing antibodies required by standard plant and bacterial toxins.

"Antibody-targeted ONCONASE is the most potent targeted ribonuclease (RNase) that I have studied," Dr. Rybak said. "While immunotoxins have entered the arsenal of anti-cancer drugs, there have been problems with their clinical use. ONCONASE's excellent performance in preclinical studies makes it a very promising candidate for testing in the clinic."

"It is a great honor to be included in this important industry reference book," added Kuslima Shogen, Alfacell's chairman and chief executive officer. "This work is further evidence of the opportunity that exists for us to build a significant ONCONASE franchise, as a single agent, in combination therapy or as a payload in antibody conjugates. ONCONASE has the potential to be an effective, highly targeted agent for the treatment of various cancers beyond mesothelioma."

For more than 25 years, Dr. Rybak's research has centered on the biology of RNases, antibody engineering and drug targeting. Her laboratory at the National Cancer Institute (NCI) developed the groundwork for RNase-based therapeutics for NHL and breast cancer. Dr. Rybak, who is a member of Alfac
'"/>




Page: 1 2 3 4

Related medicine technology :

1. In Vitro and In Vivo Data Show Alfacells Onocanse is Active Against Naive and Chemoresistant Neuroblastoma Cells
2. Preclinical Data Show Alfacells Onconase Inhibits Tumor Growth of Non-Small Cell Lung Cancer, Breast Cancer Cells
3. Researchers Identify Intracellular Pathway of Alfacells Onconase
4. In vivo Study Results Demonstrating Potential of Alfacells Onconase for Treatment of Non-Small Cell Lung Cancer Published in Anticancer Research
5. Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacells Onconase
6. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
7. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
8. Isotechnikas Lead Drug, ISA247, To Be Highlighted at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
9. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
10. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
11. Gentiums Defibrotide Highlighted in Two Poster Presentations at American Association for Cancer Research Annual Meeting

Post Your Comments:
(Date:11/25/2009)....,Nov.25/PRNewswire/--PraxisElectronicMedicalRecor...FamilyPhysicians,(AAFP)FamilyPracticeManagement(FP...quality,healthmaintenance,anddiseasemanagement,all...nked#1amongdoctorsindicatingtheirEMRhadapositiveef...kednumberoneinthecountryinprovidingexcellenttraini...
(Date:11/25/2009)...ov.25/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasda...ttedtodiscovering,developingandcommercializingnove...ltsforthefiscalyearendedSeptember30,2009.AtSeptemb...valentsandshortterminvestments. ,, PipelineUpd...2bTrial ,, InlateNovember2009,anindependentDa...
(Date:11/25/2009)...,Nov.25/PRNewswire/--TheFDAgrantedtraditionalappro...eosidereversetranscriptaseinhibitor(NNRTI).INTELEN...ment-experiencedadultswhoareexperiencingvirologicf...tiretroviral(ARV)agents.Thetraditionalapprovalisba...ndDUET-2.INTELENCEiscurrentlymarketedintheU.S.byTi...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference 13893 1PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference 13893 2DuPont Leader Says Increasing Food Production a Moral Imperative 13891 1DuPont Leader Says Increasing Food Production a Moral Imperative 13891 2DuPont Leader Says Increasing Food Production a Moral Imperative 13891 3Gerber Life Medicare Supplement Now Available Through Precision Senior Marketing 56382 1Gerber Life Medicare Supplement Now Available Through Precision Senior Marketing 56382 2
...ion Pharmaceuticals, Inc. (Nasdaq: TRBN ) announ...SCORPION(TM) multispecific therapeutic technology ...ation of Cancer Research (AACR) in Denver, April 1...gi-bin/prnh/20090320/TRUBIONLOGO ) , , The compan...and high potency of the bispecific CD79BxDR SCORPI...
...ands, April 16 The European,Association of Urolog...ientific information on randomised screening studi.... Based on the results of the European Randomised,...e EAU has formulated a,position statement regardin...sequent actions to be taken by health professional...
Other Medicine Technology:Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 2Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 3EAU Position Statement on Screening for Prostate Cancer 2
(Date:11/26/2009)... emotional rollercoaster, study finds , ,...e fear factor meets the jubilant sports fan. , ... those who root for the winning team -- enjoy the ...match and victory was in doubt, producing feelings... Thanksgiving weekend as you,re glued to the TV se...
(Date:11/26/2009)...mmunications announces a highly effective and unco...ruggling to make an economic recovery. , ...ears is the type of challenge that could send aili...to Dr. David Benton, business growth expert and au...– The Rfactor Intensive . “Fear is ...
(Date:11/25/2009)...Newswire-FirstCall/-- OnyxPharmaceuticals,Inc.(Na...oinvestoreventsinDecember: ,, ASHBriefing ,..., Principalinvestigatorswilldiscussdatapresentati...ymultiplemyeloma,asfeaturedatthe51stAmericanSociet...rleans,LA.Theteleconferencewillbeginat9:00a.m.CT/1...
(Date:11/25/2009)...ewswire-USNewswire/--AnarticlebyJanetWoodcock,M.D....rch,titled"ADifficultBalance-PainManagement,DrugSa...ewEnglandJournalofMedicine. ,, (Logo: http://ww..., Inthearticle,WoodcockdiscussesFDAeffortstostrike...editandmanagingtherisksposedbyvariousanalgesics.As...
(Date:11/25/2009)... cancer who were treated with cisplatin-based chem...eurological side effects and Raynaud-like phenomen..., according to a new study published online Novemb...tute . , Marianne Brydy, M.D., of the Department...rgen, Norway, and colleagues conducted a cross-sec...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...illings , THURSDAY, Sept. 13 (HealthDay News) -- T... to the dentist,s office, according to a team deve...que may be available to dentists and their relieve...hemical reaction to disinfect and prepare cavities...
...s, or fillings, is relatively common knowledge; ho...al system is a debate that has been ongoing for 15... will for the first time study whether prenatal ...levels of mercury exposure, Gene Watson, D.D.S, Ph...
...ily Multi-Vitamins to Young ...s summer Vitamin Relief USA, (http://www.vitaminre...com ) joined Bay St.,Louis-Waveland School Distric... district completely crushed by Hurricane,Katrina,...
...arer, study finds , THURSDAY, Sept. 13 (HealthDay ...r men over 30 have low testosterone levels, but on...linked to such a deficiency. , As men age, they ar...lain. , Low testosterone is defined as 300ng/dL (n...
...of Hurricane Felix, which ripped through the Carib...ernational relief organization, is sending,an emer...p the people,affected in Nicaragua and Honduras. ...as shipped by AmeriCares in preparation for the vi...
...stCall/ - Northstar,Healthcare Inc., (TSX:NHC) ("N...f intent to acquire an option to purchase a 60% in...mbulatory surgical center located at,5920 Forest P... 2007. Northstar,is headquartered in Houston and i...
Other Medicine News:Health News:Coming Soon: Pain-Free Dentistry 2Health News:Most comprehensive study of mercury in dental fillings begins 2Health News:Most comprehensive study of mercury in dental fillings begins 3Health News:Vitamin Relief Brings Needed Nutrition to School District Resurrecting After Katrina 2Health News:Vitamin Relief Brings Needed Nutrition to School District Resurrecting After Katrina 3Health News:Vitamin Relief Brings Needed Nutrition to School District Resurrecting After Katrina 4Health News:Vitamin Relief Brings Needed Nutrition to School District Resurrecting After Katrina 5Health News:1 in 4 Men Over 30 Has Low Testosterone 2Health News:AmeriCares Airlifts Relief to Nicaragua and Honduras 2Health News:Northstar Healthcare Announces Option to Purchase a 60% Interest in The Palladium for Surgery - Dallas 2Health News:Northstar Healthcare Announces Option to Purchase a 60% Interest in The Palladium for Surgery - Dallas 3
IMMULITE/IMMULITE 1000 Cortisol
...ors from KUBTEC represents a stand-alone, high-res...to 16 bit digital interface. The large sensing are... spacing down to 48 microns. All models are availa...ed energy range (10-160 kV). Applications range fr...
...UBTEC is a dual capability system with the ability...on of the specimen under test. While the XCAT seri...X-ray images, the micro focus source also allows t...ard 2D images. The 100 mm x 100 mm digital detecto...
...men radiography. The XPERT represents a research t...n every digital x-ray image, thus being able to ca...ore were lost to the human eye. With features incl...e, multi-color digital operator interface, and a 1...
Medicine Products: